Open access · CC-BY
via OpenAlex
Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease
Marcella Liciani Franco, Stephany Beyerstedt, Érika Bevilaqua Rangel
Pharmaceutics · 2021 · ▲ 23 citations
Stem-cell exhaustion
Chronic inflammation
Gene therapy
Stem-cell therapy
Cell culture / in vitro
In vitro
Review
Abstract
Chronic kidney disease (CKD) and acute kidney injury (AKI) are public health problems, and their prevalence rates have increased with the aging of the population. They are associated with the presence of comorbidities, in particular diabetes mellitus and hypertension, resulting in a high financial burden for the health system. Studies have indicated Klotho as a promising therapeutic approach for these conditions. Klotho reduces inflammation, oxidative stress and fibrosis and counter-regulates the renin-angiotensin-aldosterone system. In CKD and AKI, Klotho expression is downregulated from early stages and correlates with disease progression. Therefore, the restoration of its levels, through exogenous or endogenous pathways, has renoprotective effects. An important strategy for administering Klotho is through mesenchymal stem cells (MSCs). In summary, this review comprises in vitro and in vivo studies on the therapeutic potential of Klotho for the treatment of CKD and AKI through the administration of MSCs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/pharmaceutics14010011
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Franco, M.L., Beyerstedt, S., & Rangel, �.B. (2021). Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease. <em>Pharmaceutics</em>. https://doi.org/10.3390/pharmaceutics14010011
Vancouver
Franco ML, Beyerstedt S, Rangel �B. Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease. Pharmaceutics. 2021. doi:10.3390/pharmaceutics14010011.
BibTeX
@article{marcella2021Klotho,
title = {Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease},
author = {Marcella Liciani Franco and Stephany Beyerstedt and Érika Bevilaqua Rangel},
journal = {Pharmaceutics},
year = {2021},
doi = {10.3390/pharmaceutics14010011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Libyan Journal of Medical Research 2025
Open access · CC-BY
Klotho gene transfection into mesenchymal stem cells as a potential therapy for kidney disease
Cell Transplantation 2023
Open access · CC-BY
Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges
Transplantation 2022
Citation only
The Value of Klotho in Kidney Transplantation
BMC Nephrology 2018
Open access · CC-BY
The role of klotho in chronic kidney disease
American Journal of Clinical Pathology 2012
Citation only
Validation of an Immunoassay for Soluble Klotho Protein
Frontiers in Pharmacology 2022
Open access · CC-BY